Baxter is funding a clinical trial for stem cells isolated from the peripheral vein for re-infusion into the heart vessels. I think this is a convenient way of collecting stem cells and hope that this will study will show good results.
Of course, if the results are positive, this will be a huge way forward for Baxter to sell its machines to a new set of medical centres and expand their services to patients. The costs of apheresis are not small and if the volume of patients undergoing this procedure increases, this could help make prices more affordable all around, including cancer patients who are the primary users of this procedure now.
Subscribe to:
Post Comments (Atom)
Posts
No comments:
Post a Comment